(Q41842569)
Statements
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group (English)
Robert C Seeger
Wendy B London
Katherine K Matthay
Julie R Park
Judith G Villablanca
Robert B Gerbing
Daphne Haas-Kogan
E Stanton Adkins
Edward F Attiyeh
Children's Oncology Group
1 January 2009
1 reference